Povidone Iodine Market Size by Product, Application, End-Users, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2034
Overview
The Povidone Iodine Market size was valued at USD 178.42 Million in 2025 and the total Povidone Iodine revenue is expected to grow at a CAGR of 4.4% from 2026 to 2034, reaching nearly USD 262.87 Million.
Povidone Iodine Market Overview:
Povidone-iodine i.e. PVP-I, often called iodopovidone, is a disinfectant that is used to sanitize the skin before and after operations. It can be used to clean both healthcare professionals' fingers and the body of the person being cared for. It can also be used to treat minor injuries. It can be applied directly to the skin in the liquid form or talc.
Povidone Iodine Market Growth and Share Analysis
To know about the Research Methodology:- Request Free Sample Report
Skin inflammation and edema are possible side effects. When used on big wounds, it might cause renal issues, excessive blood sodium levels, and metabolic acidosis. It is not advised for women who are less than 31 weeks pregnant or who take lithium. Individuals with thyroid issues should avoid using it regularly. Povidone-iodine is a chemical compound that contains povidone, hydrogen iodide, and basic iodine. It includes 10% Povidone and 10,000 ppm of total iodine molecule, or 1% total iodine. It helps to release iodine, which causes a variety of microbes to die.
Povidone-iodine was first used commercially 67 years ago. It is on the WHO's List of Essential Medicines. Povidone-iodine is accessible without a prescription. It is marketed under a variety of trade names, notably Betadine.
In this report, the Povidone Iodine market's growth reasons, as well as the market's many segments (Application, Product, End-Users, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Povidone Iodine market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Povidone Iodine market situation.
Povidone Iodine Market Dynamics:
Because of their good effectiveness and compatibility, Iodophore-based preparations e.g. Povidone Iodine have remained relevant despite decades of usage for antisepsis and wound dressings. The broad spectrum of behavior, potential to pierce biofilms, lack of linked tolerance, anti-inflammatory characteristics, low cytotoxicity, and patient compliance of Povidone Iodine have all been highlighted as major factors, and no adverse impact on the healing process has been discovered in medical care. Recent reports about the use of Povidone Iodine have been released over the last few decades; nevertheless, many of these studies differ in methodology, outcomes, and reliability. Recent studies provide strong evidence for its efficacy in chronic wounds.
Povidone Iodine is a wide-ranging antiseptic used externally to cure wound infection. It can be used to treat small wounds, blisters, scratches, and sores in first assistance. Povidone Iodine has longer-lasting antiseptic benefits than iodine extract due to its sluggish diffusion into soft tissue, making it the preferred choice for lengthier procedures. Chlorhexidine has better benefits with the same number of side effects.
As a result, PVP-I has found widespread use in pharmaceuticals as a surgical exfoliator; for pre and post-operative skin detoxification; for the prevention and treatment of infections in injuries, lesions, cuts, and scalds; for the treatment of various diseases in chronic ulcers and mild ulcers; and in gynecology for vaginitis caused by candidal, trichomonal, or blended infections. PVP-I has been developed in concentrations ranging from 7.4-9.9 percent in solution, spray, surgeries exfoliator, lotion, and swab dosage forms for these reasons; however, while 10 percent povidone-iodine is suggested, it is rarely used because it is inadequately acknowledged by medical workers and is obnoxiously slow to dry.
Povidone Iodine Market Segment Analysis:
By Application, the Infection prevention and skin sterilization segments are expected to grow at a CAGR of 3.2% and 2.8% respectively during the forecast period. However, this growth can be hampered by the publication of contradictory studies from various authorized agencies.
The Food and Drug Administration and the Agency for Health Care Policy and Research have recently established stances that have consequences for the use of Povidone Iodine solutions in wound healing. The FDA has cleared the use of Povidone Iodine in non - prescribed disinfectant medicines. The phrase "first aid" denotes that Povidone Iodine can be used for short-term (about one week) management of small and moderate to severe wounds.
In evaluating the evidence for the use of Povidone Iodine, the FDA report states: "Controlled trials on healing process were undertaken in animals and people and encompassed diverse types of cutaneous wounds with symmetrical control, both shallow and deeper lesions were investigated. There were no statistically substantial changes in average healing times between any of the treated group and their controls, according to the findings. Furthermore, microscopic inspection revealed no variations in wound healing between the groups investigated. Povidone Iodine had no negative effects on the healing process in these pathologies and histologic examinations. However, there was no indication that Povidone Iodine could help with the healing process.
Povidone Iodine Market Regional Insights:
With a market share of more than 40%, North America leads the total Povidone Iodine market. The United States has been identified as the best end-user of Povidone Iodine in North America, owing to its high recorded rate of hospital-acquired illnesses in the US, which is boosting the market demand for antiseptics and antimicrobials and is anticipated to stay the same in the years ahead as modern lifestyle is a major trend in this territory. Moreover, regulatory bodies e.g. the FDA and the CDC have implemented severe requirements for conventional surgical antiseptics.
The APAC Povidone Iodine market is expected to exceed USD 211.9 million by , with a CAGR of more than 5.5 percent. The rapidly increasing healthcare sectors in China, India, Malaysia, and Thailand are principally responsible for the market's growth in the Asia Pacific region. Furthermore, rising awareness about infection control in healthcare, as well as increased health expenditures in the area, would drive APAC market growth in the previously mentioned forecast period.
The objective of the report is to present a comprehensive analysis of the Povidone Iodine market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Povidone Iodine market dynamics, and structure by analyzing the market segments and projecting the Povidone Iodine market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Povidone Iodine market make the report investor’s guide.
Povidone Iodine Market Recent Industry Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 1 July 2025 | Cipla Health | Cipla Health expanded its consumer wellness portfolio through targeted campaigns and distribution expansion for its povidone-iodine throat hygiene and antiseptic range. | The strategic drive reinforces broad-spectrum antiseptic self-care adoption and drives OTC retail volume growth across domestic markets. |
| 27 August 2025 | Otsuka Pharmaceutical Factory | Otsuka Pharmaceutical Factory launched Povidone Iodine Solution 10% Antiseptic Cartridges Otsuka 25 mL alongside two new surgical prep antiseptics. | The single-use cartridge-applicator system enhances procedural efficiency and infection-prevention compliance in high-throughput operating rooms. |
| 8 July 2026 | Tarsus Pharmaceuticals | Tarsus Pharmaceuticals acquired Irenix Medical to advance its ocular care pipeline, emphasizing pre-procedural povidone-iodine antisepsis protocols. | The transaction strengthens clinical standards and adoption of povidone-iodine in ophthalmic surgical preparation to reduce post-operative infection risks. |
Povidone Iodine Market Scope: Inquire before buying
| Global Povidone Iodine Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 178.42 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 4.4 % | Market Size in 2034: | USD 262.87 Mn. |
| Segments Covered: | by Product | Pharmaceutical Grade PVP-I Industrial Grade PVP-I Medical Grade PVP-I Electronic Grade |
|
| by Application | Instrument Sterilization Infection Prevention Hospitals and Clinics Skin Sterilization Breeding Industry Food Industry Aquaculture Other |
||
| by End-Users | Paints and Coatings Petrochemicals Pharmaceuticals Agrochemicals Electronics Other |
||
Povidone Iodine Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Povidone Iodine Market Key Players
1. Adani Pharmachem
2. Nanhang Industrial
3. Huaan Chemical
4. Thatcher
5. Zhongwei
6. Ashland
7. Zhangzhou Huafu Chemical Co., Ltd
8. Zen Chemicals
9. Glide Chem
10. Quat Chem
11. Sunflower
12. JH Nanhang Life Sciences Co.Ltd
13. Samrat Pharmachem Limited
14. Boai NKY Pharmaceuticals
Frequently Asked Questions:
1. Which is the potential market for the Povidone Iodine in terms of the region?
Ans. North America leads the total Povidone Iodine market.
2. What are the opportunities for new market entrants?
Ans. Recent studies provide strong evidence for its efficacy in chronic wounds.
3. What is expected to drive the growth of the Povidone Iodine market in the forecast period?
Ans. PVP-I has found widespread use in pharmaceuticals as a surgical exfoliator
4. What is the projected market size & growth rate of the Povidone Iodine Market?
Ans. Povidone Iodine Market size was valued at USD 178.42 Mn. in 2025 and the total Povidone Iodine revenue is expected to grow at 4.4% from 2026 to 2034, reaching nearly USD 262.87 Mn.
5. What segments are covered in the Povidone Iodine Market report?
Ans. The segments covered are Application, Product, End-Users, and Region.